Home Home Home Inbox Home Search

Event

P1019 Fevipiprant (QAW039) for Treatment of Patients with Uncontrolled Severe Asthma: Design of LUSTER1, a Phase III One-Year Exacerbation Study

Monday
May
22
9:15 AM
4:15 PM
Type : Scientific Abstract
Home Home Home Inbox Home Search